Приказ основних података о документу

dc.creatorJanićijević, Željko
dc.creatorRadovanović, Filip
dc.date.accessioned2018-12-05T13:49:45Z
dc.date.available2020-05-30
dc.date.issued2018
dc.identifier.issn0032-3861
dc.identifier.urihttps://dais.sanu.ac.rs/123456789/4526
dc.description.abstractWe present the innovative synthesis of polyethersulfone/poly(acrylic acid) composite hydrogel membranesperformed by combining photoirradiation with a traditional liquid phase inversion process.Fabricated membranes exhibited ion exchange capacity and water content as high as 5.2 mmol/g and75%, respectively. The chemical composition of the membranes was determined using FTIR-ATR and theirmicrostructure was examined with SEM. Our findings suggest that the use of hydrophilic crosslinker wascrucial for the synthesis of symmetric and mechanically stable composite hydrogel membranes. Passiveand iontophoretic release kinetics from membrane reservoirs synthesized with the hydrophilic crosslinkerwere investigated in vitro using methylene blue as a model drug. Passive release kinetics wasdiffusion-controlled with pH-sensitive and loading-dependent behavior. Linear release kinetics wasdemonstrated during the iontophoretic release. Synthesized composite hydrogel membranes hold a lot ofpromise as compact stand-alone reservoirs for passive and iontophoretic delivery of cationic drugs.en
dc.language.isoensr
dc.publisherElseviersr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Technological Development (TD or TR)/32008/RS//sr
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.polymer.2018.05.065
dc.relation.isversionofhttps://hdl.handle.net/21.15107/rcub_dais_3391
dc.relation.isreferencedbyhttps://hdl.handle.net/21.15107/rcub_dais_3392
dc.rightsembargoedAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourcePolymersr
dc.subjectComposite hydrogel membrane Crosslinker Ion exchange Diffusion Iontophoresis Drug releasesr
dc.titlePolyethersulfone/poly(acrylic acid) composite hydrogel membrane reservoirs for controlled delivery of cationic drug formulationsen
dc.typearticlesr
dc.rights.licenseBY-NC-NDsr
dcterms.abstractЈанићијевић, Жељко; Радовановић, Филип;
dc.citation.spage56
dc.citation.epage66
dc.description.notePublished version: [https://hdl.handle.net/21.15107/rcub_dais_3391]
dc.citation.volume147
dc.identifier.wos000436484100007
dc.identifier.doi10.1016/j.polymer.2018.05.065
dc.identifier.scopus2-s2.0-85048491046
dc.description.otherSupplementary information: [https://hdl.handle.net/21.15107/rcub_dais_3392]
dc.description.otherPublished version: [https://hdl.handle.net/21.15107/rcub_dais_3391]
dc.type.versionacceptedVersionsr
dc.identifier.fulltexthttps://dais.sanu.ac.rs/bitstream/id/14150/j.polymer.2018.05.065.pdf
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_dais_4526


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу